These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8853503)

  • 1. What studies should be undertaken in Canada to determine the value of screening for prostate cancer?
    Can J Oncol; 1994 Nov; 4 Suppl 1():119-24. PubMed ID: 8853503
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer: 4. Screening.
    Meyer F; Fradet Y
    CMAJ; 1998 Oct; 159(8):968-72. PubMed ID: 9834724
    [No Abstract]   [Full Text] [Related]  

  • 3. A prostate cancer screening trial in Canada?
    Miller A
    Can J Oncol; 1994 Nov; 4 Suppl 1():110-2; discussion 113-8. PubMed ID: 8853502
    [No Abstract]   [Full Text] [Related]  

  • 4. What studies should be undertaken in Canada to determine the value of various treatment strategies for clinically localized prostate cancer?
    Can J Oncol; 1994 Nov; 4 Suppl 1():124-7. PubMed ID: 8853504
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for prostate cancer: a urological perspective.
    Fradet Y
    Can J Oncol; 1994 Nov; 4 Suppl 1():8-12. PubMed ID: 8853480
    [No Abstract]   [Full Text] [Related]  

  • 6. The need to measure quality of life in a prostate cancer screening trial.
    Iverson D
    Can J Oncol; 1994 Nov; 4 Suppl 1():76-7. PubMed ID: 8853496
    [No Abstract]   [Full Text] [Related]  

  • 7. The European Screening Study for Prostate Cancer.
    Schröder FH
    Can J Oncol; 1994 Nov; 4 Suppl 1():102-5; discussion 106-9. PubMed ID: 8853501
    [No Abstract]   [Full Text] [Related]  

  • 8. [Screening for cancer of the prostate: a life-saver or a waste of money?].
    Rutishauser G; Graber P; Leisinger HJ; Schmid HP
    Ann Urol (Paris); 1994; 28(4):176-7. PubMed ID: 7979206
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate cancer: to screen or not to screen?
    Bonney R
    Am Clin Lab; 1995 Sep; 14(9):4. PubMed ID: 10158023
    [No Abstract]   [Full Text] [Related]  

  • 10. Rebuttal: Should Canadians be offered systematic prostate cancer screening? NO.
    Labrecque M; Légaré F; Cauchon M
    Can Fam Physician; 2007 Jul; 53(7):1140-3. PubMed ID: 17872800
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer screening.
    Sandblom G; Varenhorst E
    Cancer Causes Control; 2008 Dec; 19(10):1411. PubMed ID: 18521712
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
    Schröder FH; Roobol MJ
    BJU Int; 2009 Jan; 103(2):143-4. PubMed ID: 19076150
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology].
    Villers A; Grosclaude P; Haillot O; Abbou CC; Richard F; Boccon-Gibod L
    Prog Urol; 1997 Jun; 7(3):508-15. PubMed ID: 9273082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostate cancer screening using prostate specific antigen (PSA) in Tokatsu Hospital--examination of lost-to-followup cases].
    Shimizu N; Yamanaka H; Ichinose Y; Saitou Y
    Hinyokika Kiyo; 1998 Mar; 44(3):155-8. PubMed ID: 9589875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What will the emperor say? Screening for prostate cancer as of 2008.
    Concato J
    Cancer J; 2009; 15(1):7-12. PubMed ID: 19197166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An estimate of prostate cancer prevalence for a demographically similar workforce population.
    Westra CS; Ducatman AM; Niewiadomska-Bugaj M; Hobbs GR
    W V Med J; 1999; 95(3):116-22. PubMed ID: 10352569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Periodical medical examination update 1991: 3. Secondary prevention of prostate cancer. Canadian study group on the periodical medical examination].
    Union Med Can; 1992; 121(4):243-5, 248-57. PubMed ID: 1413294
    [No Abstract]   [Full Text] [Related]  

  • 18. Economic evaluation of prostate cancer screening with prostate-specific antigen.
    Imamura T; Yasunaga H
    Int J Urol; 2008 Apr; 15(4):285-8. PubMed ID: 18380812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should Canadians be offered systematic prostate cancer screening? No.
    Labrecque M; Légaré F; Cauchon M
    Can Fam Physician; 2007 Jun; 53(6):989-92, 994-7. PubMed ID: 17872765
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences from six years' examinations of prostatic cancer. Mass screening is not of immediate interest!].
    Varenhorst E; Carlsson P; Hagström I; Lindahl T; Löfman O; Brage HN; Pedersen K; Wägermark J
    Lakartidningen; 1996 Aug; 93(35):2940-6. PubMed ID: 8815354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.